StockData
KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31

KAMADA LTD

Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 11, 2026
$7.61−0.15 (-1.93%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
21.7
Dividend yield
–

Community

Notes and questions about Kamada from other investors

No posts about KMDA yet

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.